233 related articles for article (PubMed ID: 30967262)
21. C5a/C5aR1 mediates IMQ-induced psoriasiform skin inflammation by promoting IL-17A production from γδ-T cells.
Zheng QY; Xu F; Yang Y; Sun DD; Zhong Y; Wu S; Li GQ; Gao WW; Wang T; Xu GL; Liang SJ
FASEB J; 2020 Aug; 34(8):10590-10604. PubMed ID: 32557852
[TBL] [Abstract][Full Text] [Related]
22. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
van der Fits L; Mourits S; Voerman JS; Kant M; Boon L; Laman JD; Cornelissen F; Mus AM; Florencia E; Prens EP; Lubberts E
J Immunol; 2009 May; 182(9):5836-45. PubMed ID: 19380832
[TBL] [Abstract][Full Text] [Related]
23. p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation.
Zheng T; Zhao W; Li H; Xiao S; Hu R; Han M; Liu H; Liu Y; Otsu K; Liu X; Huang G
Sci Signal; 2018 Mar; 11(521):. PubMed ID: 29535261
[TBL] [Abstract][Full Text] [Related]
24. IRF-2 haploinsufficiency causes enhanced imiquimod-induced psoriasis-like skin inflammation.
Kawaguchi M; Oka T; Sugaya M; Suga H; Kimura T; Morimura S; Fujita H; Sato S
J Dermatol Sci; 2018 Apr; 90(1):35-45. PubMed ID: 29305258
[TBL] [Abstract][Full Text] [Related]
25. Resident and monocyte-derived Langerhans cells are required for imiquimod-induced psoriasis-like dermatitis model.
Lee M; Kim SH; Kim TG; Park J; Lee JW; Lee MG
J Dermatol Sci; 2018 Jul; 91(1):52-59. PubMed ID: 29655588
[TBL] [Abstract][Full Text] [Related]
26. MAD ointment ameliorates Imiquimod-induced psoriasiform dermatitis by inhibiting the IL-23/IL-17 axis in mice.
OuYang Q; Pan Y; Luo H; Xuan C; Liu J; Liu J
Int Immunopharmacol; 2016 Oct; 39():369-376. PubMed ID: 27540765
[TBL] [Abstract][Full Text] [Related]
27. Hydroxychloroquine exacerbates imiquimod-induced psoriasis-like dermatitis through stimulating overexpression of IL-6 in keratinocytes.
Yen LJ; Chen YC; Wang KC; Shih MC; Li CL; Yu SJ; Lu LY
Immunopharmacol Immunotoxicol; 2024 Feb; 46(1):128-137. PubMed ID: 38059657
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of interleukin-2-inducible T-cell kinase causes reduction in imiquimod-induced psoriasiform inflammation through reduction of Th17 cells and enhancement of Treg cells in mice.
Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Alqahtani F; As Sobeai HM; Alotaibi MR
Biochimie; 2020 Dec; 179():146-156. PubMed ID: 33007409
[TBL] [Abstract][Full Text] [Related]
29. Effects of tumor necrosis factor-like ligand 1A (TL1A) on imiquimod-induced psoriasiform skin inflammation in mice.
Li L; Fu L; Zhou P; Lu Y; Zhang L; Wang W; Nie J; Zhang D; Liu Y; Wu B; Chen T
Arch Dermatol Res; 2020 Sep; 312(7):481-490. PubMed ID: 31953572
[TBL] [Abstract][Full Text] [Related]
30. Apremilast downregulates interleukin-17 production and induces splenic regulatory B cells and regulatory T cells in imiquimod-induced psoriasiform dermatitis.
Uchida H; Kamata M; Shimizu T; Egawa S; Ito M; Takeshima R; Mizukawa I; Watanabe A; Tada Y
J Dermatol Sci; 2021 Oct; 104(1):55-62. PubMed ID: 34548208
[TBL] [Abstract][Full Text] [Related]
31. Diet-induced obesity exacerbates imiquimod-mediated psoriasiform dermatitis in anti-PD-1 antibody-treated mice: Implications for patients being treated with checkpoint inhibitors for cancer.
Yu S; Wu X; Shi Z; Huynh M; Jena PK; Sheng L; Zhou Y; Han D; Wan YY; Hwang ST
J Dermatol Sci; 2020 Mar; 97(3):194-200. PubMed ID: 32044178
[TBL] [Abstract][Full Text] [Related]
32. Osteopontin deficiency affects imiquimod-induced psoriasis-like murine skin inflammation and lymphocyte distribution in skin, draining lymph nodes and spleen.
Frenzel DF; Borkner L; Scheurmann J; Singh K; Scharffetter-Kochanek K; Weiss JM
Exp Dermatol; 2015 Apr; 24(4):305-7. PubMed ID: 25655893
[TBL] [Abstract][Full Text] [Related]
33. Interleukin-33 alleviates psoriatic inflammation by suppressing the T helper type 17 immune response.
Chen Z; Hu Y; Gong Y; Zhang X; Cui L; Chen R; Yu Y; Yu Q; Chen Y; Diao H; Chen J; Wang Y; Shi Y
Immunology; 2020 Aug; 160(4):382-392. PubMed ID: 32306382
[TBL] [Abstract][Full Text] [Related]
34. An Interleukin-25-Mediated Autoregulatory Circuit in Keratinocytes Plays a Pivotal Role in Psoriatic Skin Inflammation.
Xu M; Lu H; Lee YH; Wu Y; Liu K; Shi Y; An H; Zhang J; Wang X; Lai Y; Dong C
Immunity; 2018 Apr; 48(4):787-798.e4. PubMed ID: 29653697
[TBL] [Abstract][Full Text] [Related]
35. TRPV1 mediates inflammation and hyperplasia in imiquimod (IMQ)-induced psoriasiform dermatitis (PsD) in mice.
Zhou Y; Follansbee T; Wu X; Han D; Yu S; Domocos DT; Shi Z; Carstens M; Carstens E; Hwang ST
J Dermatol Sci; 2018 Dec; 92(3):264-271. PubMed ID: 30527377
[TBL] [Abstract][Full Text] [Related]
36. Targeting STING in dendritic cells alleviates psoriatic inflammation by suppressing IL-17A production.
Sun X; Liu L; Wang J; Luo X; Wang M; Wang C; Chen J; Zhou Y; Yin H; Song Y; Xiong Y; Li H; Zhang M; Zhu B; Li X
Cell Mol Immunol; 2024 Jul; 21(7):738-751. PubMed ID: 38806624
[TBL] [Abstract][Full Text] [Related]
37. Nociceptive sensory neurons drive interleukin-23-mediated psoriasiform skin inflammation.
Riol-Blanco L; Ordovas-Montanes J; Perro M; Naval E; Thiriot A; Alvarez D; Paust S; Wood JN; von Andrian UH
Nature; 2014 Jun; 510(7503):157-61. PubMed ID: 24759321
[TBL] [Abstract][Full Text] [Related]
38. Acetyl-11-keto-β-boswellic acid inhibits the secretion of cytokines by dendritic cells via the TLR7/8 pathway in an imiquimod-induced psoriasis mouse model and in vitro.
Wang MX; Zhao JX; Meng YJ; Di TT; Xu XL; Xie XJ; Lin Y; Zhang L; Wang N; Li P; Wang Y
Life Sci; 2018 Aug; 207():90-104. PubMed ID: 29859222
[TBL] [Abstract][Full Text] [Related]
39. Liraglutide improved inflammation
Chen P; Lin L; Xu X; Zhang Z; Cai W; Shao Z; Chen S; Chen X; Weng Q
J Dermatolog Treat; 2021 Nov; 32(7):745-751. PubMed ID: 31868553
[TBL] [Abstract][Full Text] [Related]
40. Imiquimod has strain-dependent effects in mice and does not uniquely model human psoriasis.
Swindell WR; Michaels KA; Sutter AJ; Diaconu D; Fritz Y; Xing X; Sarkar MK; Liang Y; Tsoi A; Gudjonsson JE; Ward NL
Genome Med; 2017 Mar; 9(1):24. PubMed ID: 28279190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
